Productivity Rankings is an exclusive service provided by AD Scientific Index. This ranking system, derived from the i10 index, highlights the productivity of scientists in publishing impactful scientific articles. Productivity Rankings serves as a tool to identify highly productive scientists across specific areas, disciplines, universities, and countries, and supports the creation of effective incentives and academic policies. The global, regional, and institutional rankings of scientists in this table are calculated based on their total i10 index. Moreover, you can explore special rankings derived from Productivity Rankings, such as Scientists Last 6 Years' i10 Index, Universities Total i10 Index Rankings 2025, Universities Last 6 Years' i10 Index Rankings 2025, Art and Humanities i10 Productivity Rankings, and Social Sciences and Humanities i10 Productivity Rankings.
* Total i10 IndexRankings
Ranking Based On Selection :1
transporters
drug metabolism
pharmacokinetics
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
290
135
0.466
* Total i10 IndexRankings
Ranking Based On Selection :2
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
244
131
0.537
* Total i10 IndexRankings
Ranking Based On Selection :3
Homogeneous catalysis
reaction mechanisms
molecular modeling
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
193
95
0.492
* Total i10 IndexRankings
Ranking Based On Selection :4
cardiology
lipids
hypertension
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
183
53
0.290
* Total i10 IndexRankings
Ranking Based On Selection :5
Drug metabolism and disposition
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
177
77
0.435
* Total i10 IndexRankings
Ranking Based On Selection :6
Data Science
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
164
138
0.841
* Total i10 IndexRankings
Ranking Based On Selection :7
Oncology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
143
130
0.909
* Total i10 IndexRankings
Ranking Based On Selection :8
Cheminformatics
Drug Discovery
Machine Learning
Semantic Web Technologies
Open Innovation
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
138
111
0.804
* Total i10 IndexRankings
Ranking Based On Selection :9
statistics
clinical trials
regulatory submission for drug development
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
138
73
0.529
* Total i10 IndexRankings
Ranking Based On Selection :10
Genomics
Bioinformatics
Oncology
Data Science
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
134
48
0.358
* Total i10 IndexRankings
Ranking Based On Selection :11
CAR-T
Treg
iPSC
genome editing
lentiviral and AAV vectors
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
133
75
0.564
* Total i10 IndexRankings
Ranking Based On Selection :12
Quantitative Clinical Pharmacology
Anesthesiology
Pharmacometrics
Clinical Pharmacology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
131
42
0.321
* Total i10 IndexRankings
Ranking Based On Selection :13
Proteomics
Cell Biology
Bioanalytical Chemistry
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
123
84
0.683
* Total i10 IndexRankings
Ranking Based On Selection :14
Clinical Pharmacology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
120
79
0.658
* Total i10 IndexRankings
Ranking Based On Selection :15
Clinical Trials
Longitudinal Data
Evidence Synthesis
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
111
101
0.910
* Total i10 IndexRankings
Ranking Based On Selection :16
Cancer
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
110
52
0.473
* Total i10 IndexRankings
Ranking Based On Selection :17
Physiology
Metabolism
Transgenic
CRISPR
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
105
83
0.790
* Total i10 IndexRankings
Ranking Based On Selection :18
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
103
73
0.709
* Total i10 IndexRankings
Ranking Based On Selection :19
drug discovery and development
viruses and epithelial biology
non coding RNA
post translational modification
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
99
62
0.626
* Total i10 IndexRankings
Ranking Based On Selection :20
Developing inhibitors of the DNA Damage Response into new medicines for cancer patients
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
96
83
0.865
* Total i10 IndexRankings
Ranking Based On Selection :21
meta-analysis
missing data
statistics
biostatistics
miscellaneous statistical theory
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
95
83
0.874
* Total i10 IndexRankings
Ranking Based On Selection :22
Pharmacology
Drug Development
Pharmacokinetics
Modeling
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
87
18
0.207
* Total i10 IndexRankings
Ranking Based On Selection :23
Immunotherapy
microbiome
and targeted therapy for oncology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
85
79
0.929
* Total i10 IndexRankings
Ranking Based On Selection :24
molecular pharmacology
oncology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
85
64
0.753
* Total i10 IndexRankings
Ranking Based On Selection :25
medicinal chemistry
drug discovery
oncology & infectious diseases
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
85
51
0.600
Anshul Gupta
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
290
135
0.466
transporters
drug metabolism
pharmacokinetics
Outi Vaarala
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
244
131
0.537
Per-Ola Norrby
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
193
95
0.492
Homogeneous catalysis
reaction mechanisms
molecular modeling
Björn W Karlson
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
183
53
0.290
cardiology
lipids
hypertension
Tommy B Andersson
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
177
77
0.435
Drug metabolism and disposition
Noel Southall
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
164
138
0.841
Maurizio Scaltriti
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
143
130
0.909
Ola Engkvist
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
138
111
0.804
Cheminformatics
Drug Discovery
Machine Learning
Semantic Web Technologies
Open Innovation
Jenny Han
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
138
73
0.529
statistics
clinical trials
regulatory submission for drug development
Justin H. Johnson
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
134
48
0.358
Genomics
Bioinformatics
Oncology
Data Science
Yasuhiro İkeda
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
133
75
0.564
CAR-T
Treg
iPSC
genome editing
lentiviral and AAV vectors
Donald Stanski
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
131
42
0.321
Quantitative Clinical Pharmacology
Anesthesiology
Pharmacometrics
Clinical Pharmacology
Sonja Hess
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
123
84
0.683
Proteomics
Cell Biology
Bioanalytical Chemistry
David Boulton
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
120
79
0.658
Michael Sweeting
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
111
101
0.910
Cristiano Ferlini
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
110
52
0.473
Mohammad Bohlooly-Y
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
105
83
0.790
Physiology
Metabolism
Transgenic
CRISPR
Mark Birrell
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
103
73
0.709
Rose A Maciewicz
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
99
62
0.626
drug discovery and development
viruses and epithelial biology
non coding RNA
post translational modification
Mark J O'Connor
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
96
83
0.865
Developing inhibitors of the DNA Damage Response into new medicines for cancer patients
Dan Jackson
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
95
83
0.874
meta-analysis
missing data
statistics
biostatistics
miscellaneous statistical theory
Ulf G Eriksson
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
87
18
0.207
Pharmacology
Drug Development
Pharmacokinetics
Modeling
Zachary A Cooper
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
85
79
0.929
Immunotherapy
microbiome
and targeted therapy for oncology
Sylvie Guichard
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
85
64
0.753
molecular pharmacology
oncology
David Matthew Wilson
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
85
51
0.600
medicinal chemistry
drug discovery
oncology & infectious diseases